Details for New Drug Application (NDA): 020227
✉ Email this page to a colleague
The generic ingredient in NORMIFLO is ardeparin sodium. Additional details are available on the ardeparin sodium profile page.
Summary for 020227
Tradename: | NORMIFLO |
Applicant: | Pharmacia And Upjohn |
Ingredient: | ardeparin sodium |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 10,000 UNITS/0.5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | May 23, 1997 | TE: | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 5,000 UNITS/0.5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | May 23, 1997 | TE: | RLD: | Yes |
Complete Access Available with Subscription